AIM
CHRS icon

Aigen Investment Management’s Coherus Oncology CHRS Stock Holding History

Aigen Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,325
Closed -$31.8K – 806
2024
Q1 		$31.8K Buy
+13,325
New +$32.8K 0.01% 637
2021
Q2 		– Sell
-46,735
Closed -$683K – 510
2021
Q1 		$683K Buy
46,735
+21,396
+84% +$363K 0.09% 236
2020
Q4 		$440K Buy
25,339
+6,156
+32% +$110K 0.06% 427
2020
Q3 		$352K Sell
19,183
-14,931
-44% -$278K 0.04% 492
2020
Q2 		$609K Buy
+34,114
New +$577K 0.08% 402

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aigen Investment Management's CHRS Position: Q2 2024 in Review

Aigen Investment Management sold out of Coherus Oncology (CHRS) in Q2 2024, closing a stake of 13,325 shares — an estimated $31.8K sold.

Aigen Investment Management first reported a position in CHRS in Q2 2020 and held it in 5 quarters. The position peaked at $683K in Q1 2021. 135 funds tracked by Wall St. Rank hold CHRS as of Q2 2024.

  • Aigen Investment Management reported no remaining Coherus Oncology position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 13,325 Coherus Oncology shares in Q2 2024, an estimated $31.8K.
  • Aigen Investment Management first reported a position in Coherus Oncology in Q2 2020 and held it in 5 quarters.
  • Aigen Investment Management's Coherus Oncology position peaked at $683K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.